Bedrijf laden
CVSCVS Health CorpUS$ 114,3BAJust reported
From Humana's results release of 6 november 2026; its quarterly report has since been filed.
Actual
US$ 41,16B
+26% y/y
+0,7% q/q
Guided
—
No guide given
Actual
US$ 1,33
-18% y/y
-77% q/q
Guided
—
No guide given
Actual
US$ 75M
-81% y/y
-94% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →De omzetaandelen zijn schattingen voor quarter ended March 31, 2026, geen cijfers uit een ingediend rapport.
Medicare Advantage plans
Health plans for people eligible for Medicare that cover hospital and medical care, often with prescription drugs, care coordination and extra benefits.
Medicare Part D prescription drug plans
Prescription coverage sold either as a stand-alone plan or as part of many Medicare Advantage plans.
Medicaid managed-care plans
Health coverage for people eligible for Medicaid, provided under contracts with state governments.
Medicare Supplement and employer specialty insurance
Medicare Supplement plans help pay costs not covered by traditional Medicare; employer specialty policies cover benefits such as dental, vision, life and disability.
CenterWell Pharmacy
A mail-order and specialty pharmacy that fills prescriptions and supplies medicines and health products.
CenterWell primary and home care
Primary-care clinics focused mainly on older adults, home health visits, and coordination of services such as home infusion and medical equipment.
Humana’s largest business sells health insurance plans, especially Medicare Advantage plans, which cover hospital and medical care and often include prescription drugs. The federal Centers for Medicare & Medicaid Services pays Humana for much of this coverage; Humana also contracts with states for Medicaid plans and sells insurance to employers and individuals. Its CenterWell businesses provide pharmacy services, primary care and care in patients’ homes.
Gebouwd uit de eigen deponeringen van Humana Inc. bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
The themes Humana is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$ 450,27+1,4%slot 13 nov
Cijfers tot en met 30 september 2026, uit de 10-Q ingediend op 6 november 2026
Humana sells Medicare Advantage health insurance to older adults and people with disabilities, alongside prescription coverage and care services.
Grade B
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 40 kwartalen van de cijferhistorie van Humana Inc.. De andere 38 lopen terug tot november 2016.
